feed,title,long_url,short_url
Benzinga,Seres Therapeutics Stock Plunges As Ulcerative Colitis Candidate Disappoints In Mid-Stage Study,https://benzinga.com/general/biotech/21/07/22100534/seres-therapeutics-stock-plunges-as-ulcerative-colitis-candidate-disappoints-in-mid-stage-study,https://j.mp/36Sdvur
Benzinga,"Heron Therapeutics' Zynrelef Shows Reduction In Post-Op Pain, Opioid Use Compared To Bupivacaine In Old-Aged Patients",https://benzinga.com/general/biotech/21/07/22099905/heron-therapeutics-zynrelef-shows-reduction-in-post-op-pain-opioid-use-compared-to-bupivacaine-in,https://j.mp/3iyuOpX
Benzinga,"Danaher Posts Higher Profits, Margins On Increased Sales",https://benzinga.com/general/biotech/21/07/22099469/danaher-posts-higher-profits-margins-on-increased-sales,https://j.mp/3iyuNSV
